Shukra Pharmaceuticals Ltd - Board Meeting Intimation for Considering And Approving Audited Financial Result For The Quarter And Financial Year Ended March 31, 2023 And Other Businesses.

Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve 1. Audited financial result for the quarter and financial year ended on 31st March, 2023 along with the Auditor''s Report and Certificate for unmodified opinion Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015. 2. Recommend final dividend to the members of the company for the financial year 2022-23. 3. Any other business with the permission of Chairman.